ENTITY
Celltrion

Celltrion (068270 KP)

21
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Refresh
10 Dec 2018 12:11

Smartkarma’s Week That Was in JP/​​​​​KR: Softbank, Nissan, & A Star Is Born in 2018 Rewind to 1937

The year is winding down and there are only three weeks left in 2018. The sentiment on the global stock markets has been turning down rapidly in...

Logo
373 Views
Share
02 Dec 2018 21:29

The Smartkarma Week That Was in JP/KR: Nissan, J-Retail, Tesla/Panny, SK Rights, Biosimilars, Trade

This past week featured ~160 insights across the Smartkarma platform, with 35+ of them dealing with Japan, South Korea, and semiconductors/memory...

Logo
899 Views
Share
bearishCelltrion Inc
28 Nov 2018 00:29

Biosimilar Battlefield Update: It's Getting Uglier

A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...

Share
27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
339 Views
Share
bearishBombardier Inc
16 Nov 2018 11:07

Reality Overwhelms Creative Accounting

Bombardier Inc (BBD/B CN) has recently fallen 38%, ThyssenKrupp AG (TKA GR) 18%  and Celltrion Inc (068270 KS) 30%.  In each case, the market was...

x